ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-1,198 Cr | ₹-1,068 Cr | ₹-942 Cr | ₹-955 Cr | ₹-643 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-1,198 Cr |
Mar2023 | ₹-1,068 Cr |
Mar2022 | ₹-942 Cr |
Mar2021 | ₹-955 Cr |
Mar2020 | ₹-643 Cr |
How is Deferred Tax Assets / Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,198 Cr | Negative | |
Mar2023 | ₹-1,068 Cr | Negative | |
Mar2022 | ₹-942 Cr | Negative | |
Mar2021 | ₹-955 Cr | Negative | |
Mar2020 | ₹-643 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹90,719.0 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,787.0 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
MANKIND PHARMA | ₹98,888.9 Cr | -4.4% | -7.8% | 13.3% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -6.5% |
-9.3% |
8.6% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses